세계의 디지털 당뇨병 관리 시장(2024-2031년)

Digital Diabetes Management Market Size, Share & Trends Analysis Report by Products & Services (Devices, Applications, Data Management Software & Platforms, and Services), by Device Type (Wearable Devices, and Hand-Held Devices), and by End-User (Hospitals, and Home Settings) Forecast Period (2024-2031)

Digital diabetes management market is anticipated to grow at a CAGR of 14.6% during the forecast period (2024-2031). Digital diabetes management refers to the use of technology-based tools and applications to aid individuals in managing their diabetes. These digital solutions can include mobile apps, online platforms, and connected devices that track and analyze health data such as blood glucose levels, diet, exercise, and medication adherence. The growing need for the on-time management of diabetes to limit its impact on health is a major motivator for the growth of this global market.

Market Dynamics

Advancements in Digital Health Technology

The ongoing advancements in digital health technology, such as continuous glucose monitoring (CGM) systems, smart insulin pens, and advanced data analytics, are propelling the market forward. CGMs can alert users when the glucose levels are rising or dropping, and how quickly. This can help users to decide how to reach their target range. For instance, if your blood sugar is 110 and an arrow is pointing down, it could mean that your blood sugar could drop to 60-90 points in 30 minutes, which might not be safe. Advancements in digital diabetes management products and services allow users to make informed decisions, which leads to fewer emergencies.

Rising Focus on Personalized Healthcare

Personalized healthcare in digital diabetes management is a patient-centered approach that tailors treatment and management strategies to individual patient needs and preferences. Digital Twins and Personal Health Knowledge Graphs (PHKGs), Continuous Glucose Monitoring (CGM), Virtual Care and Telehealth, Mobile Health Apps, and Artificial Intelligence (AI). These innovative concepts involve creating a digital replica of a patient's health profile and integrating data from diverse sources to provide real-time, patient-centric care. Personalized virtual care using telehealth services, including CGM, can improve glycemic control and reduce diabetes-related distress.

Market segmentation

• Based on product the market is segmented into devices, applications, data management software & platforms, and services. Based on devices, the market is sub-segmented into smart glucose meters, smart insulin pens, and continuous glucose monitoring (CGM) systems.
• Based on application, the market is sub-segmented into diabetes & blood glucose tracking Apps, and obesity & diet management Apps.
• Based on type, the market is segmented into wearable devices and hand-held devices.
• Based on the end-user, the market is segmented into hospitals and home settings.

Hospitals Lead the Way in the Digital Diabetes Management Market

Hospitals play a crucial role in digital diabetes management by integrating advanced technologies into their care protocols to provide better outcomes for patients with diabetes. Hospitals are increasingly integrating patient data from various digital sources into their Electronic Health Records (EHR) systems for a more comprehensive view of a patient's health status. Additionally, hospitals are at the forefront of research into new digital diabetes management technologies, often conducting clinical trials to test the efficacy and safety of new devices and apps.

Regional Outlook

The global digital diabetes management market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America holds largest market share

The advanced healthcare regional infrastructure is conducive to the adoption of new technologies. Robust research and development infrastructure along with growing funding for diabetes research is further aiding the regional market share. The significant presence of the diabetic population along with new product launches to meet user's demands is further driving the regional market growth. For instance, in October 2023, Insulet received 510(k) clearance from the Food and Drug Administration for its Omnipod 5 application on iPhone, which allows people to control their insulin pump from a smartphone. Insulet included an Android app when it first launched its Omni pod 5 pump last year. The iPhone app has the same functions with a few new features.

The major companies serving in the global digital diabetes management market include Abbott Laboratories, B. Braun Melsungen AG, Medtronic Plc, DarioHealth Corp., and Sanofi SA among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Market Trends
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Abbott Laboratories
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. B. Braun Melsungen AG
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Medtronic PLC
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Digital Diabetes Management Market by Products & Services
  • 4.1.1. Devices
    • 4.1.1.1. Smart Glucose Meters
    • 4.1.1.2. Smart Insulin Pens
    • 4.1.1.3. Continuous Glucose Monitoring (CGM) Systems
  • 4.1.2. Application
    • 4.1.2.1. Diabetes & Blood Glucose Tracking Apps
    • 4.1.2.2. Obesity & Diet Management Apps
  • 4.1.3. Data Management Software & Platforms
  • 4.1.4. Services
• 4.2. Global Digital Diabetes Management Market by Device Type
  • 4.2.1. Wearable Device
  • 4.2.2. Hand-held Device
• 4.3. Global Digital Diabetes Management Market by End-User
  • 4.3.1. Hospitals
  • 4.3.2. Home Settings

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World
  • 5.4.1. Latin America
  • 5.4.2. Middle East & Africa

6. Company Profiles

• 6.1. Agamatrix Inc.
• 6.2. Ascensia Diabetes Care Holdings AG
• 6.3. B. Braun Melsungen AG
• 6.4. Bayer AG
• 6.5. Braun Melsungen AG
• 6.6. Care Innovations, LLC
• 6.7. Dariohealth Corp.
• 6.8. Dexcom Inc.
• 6.9. F. Hoffmann-La Roche Ltd.
• 6.10. Glooko Inc.
• 6.11. Hoffmann-La Roche Ltd.
• 6.12. Insulet Corp.
• 6.13. LifeScan, Inc.
• 6.14. One Drop, Inc.
• 6.15. Sanofi SA
• 6.16. Tandem Diabetes Care, Inc.
• 6.17. Tidepool